Continuous intravenous infusion of enoxaparin controls thrombin formation more than standard subcutaneous administration in critically ill patients. A sub-study of the ENOKSI thromboprophylaxis RCT

Annukka Vahtera, Timea Szanto, Riitta Lassila, Miia Valkonen, Mirka Sivula, Heini Huhtala, Ville Pettilä, Anne Kuitunen

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalActa Anaesthesiologica Scandinavica
Volume65
Issue number1
Pages (from-to)109-115
Number of pages7
ISSN0001-5172
DOIs
Publication statusPublished - Jan 2021
MoE publication typeA1 Journal article-refereed

Fields of Science

  • Blood Coagulation Factor
  • Enoxaparin
  • Heparin
  • Low-Molecular-Weight
  • Intensive Care Unit
  • Thromboprophylaxis
  • MOLECULAR-WEIGHT HEPARIN
  • DISSEMINATED INTRAVASCULAR COAGULATION
  • CALIBRATED AUTOMATED THROMBOGRAM
  • FACTOR PATHWAY INHIBITOR
  • PROTHROMBIN FRAGMENT 1+2
  • ED AMERICAN-COLLEGE
  • UNFRACTIONATED HEPARIN
  • D-DIMER
  • ANTITHROMBOTIC THERAPY
  • IN-VITRO

Cite this